抗血管内皮生长因子治疗后早期3型新生血管的光学相干断层扫描血管成像变化
本研究回顾性纳入15例未治疗早期3型新生血管患者,抗VEGF治疗12个月后OCTA显示深毛细血管丛异常持续13/15眼,外层视网膜和毛细血管层初始病灶7/15眼不可见并伴毛细血管层萎缩,9/15眼外层视网膜分割可见簇状异常血管复合体持续,其中8例在毛细血管层分割与视网膜下色素上皮新生血管相关。
要点
- 抗VEGF治疗12个月后OCTA显示深毛细血管丛异常持续13/15眼。
- 外层视网膜和毛细血管层初始病灶7/15眼不可见,伴毛细血管层萎缩。
- 外层视网膜分割簇状异常血管复合体持续9/15眼,其中8例与视网膜下色素上皮新生血管相关。
核心结论
- OCTA显示抗VEGF治疗1年后,簇状异常外层视网膜病灶常伴毛细血管层小线团样血流信号,或变得不可见,或发展为视网膜下色素上皮新生血管。
研究设计与样本
- 回顾性研究纳入连续15例未治疗早期3型新生血管患者的15只眼。
- 基线行彩色眼底照相/MultiColor成像、荧光素血管造影、吲哚菁绿血管造影、结构谱域OCT和OCTA Optovue RTVue XR Avanti检查,第12个月重复OCTA和结构谱域OCT。
- 比较基线与第12个月3×3 OCTA检查的定性分析,评估抗VEGF治疗后的变化。
主要发现
- 12个月随访时,抗VEGF治疗(雷珠单抗5.75±1.48次注射,阿柏西普6.33±1.21次注射)后OCTA显示深毛细血管丛异常持续13/15眼。
- 外层视网膜和毛细血管层初始病灶7/15眼不可见,伴毛细血管层萎缩。
- 外层视网膜分割簇状异常血管复合体持续9/15眼,其中8例在毛细血管层分割与视网膜下色素上皮新生血管相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the morphologic changes on optical coherence tomography angiography (OCTA) of treatment-naive Type 3 neovascularization secondary to exudative age-related macular degeneration after 1 year of anti-vascular endothelial growth factor therapy. METHODS: Consecutive patients diagnosed with treatment-naive early-stage Type 3 neovascularization were enrolled in this retrospective study. All patients underwent color fundus photographs/MultiColor (Heidelberg Engineering) imaging, fluorescein angiography, indocyanine green angiography, structural spectral domain OCT, and OCTA Optovue RTVue XR Avanti (Optovue) at baseline, and repeated OCTA and structural spectral domain OCT at Month 12. Qualitative analysis of the 3 × 3 OCTA examinations at baseline and Month 12 was then compared, to assess changes after anti-vascular endothelial growth factor therapy. RESULTS: A total of 15 treatment-naive eyes of 15 consecutive patients were included in the analysis. At 12-month follow-up after pro-re-data anti-vascular endothelial growth factor therapy (5.75 ± 1.48 injections of ranibizumab, and injections of 6.33 ± 1.21 of aflibercept), OCTA demonstrated persistence of the deep capillary plexus abnormalities in 13/15 eyes. In the outer retina and choriocapillaris, the initial lesion became undetectable in 7/15 cases, accompanied by choriocapillaris atrophy. The abnormal vascular complex persisted in the form of a tuft-shaped lesion in the outer retinal segmentation in 9/15 eyes, which in the choriocapillaris segmentation was associated with sub-retinal pigment epithelium neovascularization in 8 cases. CONCLUSION: Optical coherence tomography angiography showed that the tuft-shaped abnormal outer retinal lesion, frequently associated with a small clew-like flow signal in the choriocapillaris, after 1 year of anti-vascular endothelial growth factor therapy, either becomes undetectable or develops sub-retinal pigment epithelium neovascularization.
引用
- Miere A, Querques G, Semoun O, et al. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT. Retina. 2017. PMID: 28079756. doi:10.1097/IAE.0000000000001447
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。